Related Experiment Video
Updated: Oct 15, 2025

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
Multiple strategies for the treatment of invasive breast carcinoma: A comprehensive prospective
Shivangi Agarwal1, Samaresh Sau2, Arun K Iyer3
1Department of Pharmaceutical Sciences, Dr Harisingh Gour University, Sagar, MP, India.
Abstract:
In this review, we emphasize on evolving therapeutic strategies and advances in the treatment of breast cancer (BC). This includes small-molecule inhibitors under preclinical and clinical investigation, phytoconstituents with antiproliferative potential, targeted therapies as antibodies and antibody-drug conjugates (ADCs), vaccines as immunotherapeutic agents and peptides as a novel approach inhibiting the interaction of oncogenic proteins. We provide an update of molecules under different phases of clinical investigation which aid in the identification of loopholes or shortcomings that can be overcomed with future breast cancer research.
Insights
This review highlights new breast cancer (BC) treatments, including targeted therapies, immunotherapies, and novel small molecules. Future research can address current limitations in BC treatment strategies.
Area of Science:
- Oncology
- Pharmacology
- Immunotherapy
Background:
- Breast cancer (BC) remains a leading cause of cancer-related mortality worldwide.
- Continuous innovation in therapeutic strategies is crucial for improving patient outcomes.
- Existing treatments face challenges such as resistance and toxicity.
Purpose of the Study:
- To review and summarize recent advances in breast cancer therapeutics.
- To highlight emerging treatment modalities including small-molecule inhibitors, phytoconstituents, targeted therapies, vaccines, and peptides.
- To identify gaps and future directions for breast cancer research.
Main Methods:
- Comprehensive literature review of preclinical and clinical studies.
- Analysis of evolving therapeutic strategies and novel agents.
- Focus on molecules in various phases of clinical investigation.
Main Results:
- Small-molecule inhibitors show promise in preclinical and clinical settings.
- Phytoconstituents exhibit antiproliferative effects against breast cancer cells.
- Targeted therapies, including antibody-drug conjugates (ADCs), offer new treatment avenues.
- Immunotherapeutic vaccines and peptides targeting oncogenic protein interactions are under investigation.
Conclusions:
- The landscape of breast cancer treatment is rapidly evolving with diverse therapeutic approaches.
- Emerging therapies like ADCs and peptide-based treatments hold significant potential.
- Further research is needed to overcome existing challenges and optimize future breast cancer therapies.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy